|
| Human NKG2C/CD159c Protein (LTP10125) |
|
| LTP10125 |
|
| 100ug |
|
|
$473 In stock |
| As a first line of defense, natural killer (NK) cells play a crucial role in the fight against infections.The presented study is the first of its kind that ascribes CD56dimCD16 NKG2C-expressing NK cells a crucial role in biasing adaptive immune responses upon influenza vaccination and suggests NKG2C as a potential biomarker in predicting pandemic influenza vaccine responsiveness. |
| Recombinant Human NKG2C/CD159c Protein is expressed from Expi293 with hFc tag at the C-terminal. It contains Glu98-Leu231. |
|
| NKG2C/CD159c |
|
| Human |
|
| P26717 |
|
| Glu98-Leu231 |
|
| The protein has a predicted MW of 42.07 kDa. Due to glycosylation, the protein migrates to 48-58 kDa based on the Tris-Bis PAGE result. |
|
| 0 |
|
| C-hFc |
|
| Expi293 |
|
| > 95% as determined by Tris-Bis PAGE; > 95% as determined by HPLC |
|
| Less than 1EU per ug by the LAL method. |
|
| Lyophilized from 0.22 um filtered solution in PBS (pH 7.4). Normally 8% trehalose is added as a protectant before lyophilization. |
|
| Reconstituted protein stable at -80 C for 12 months, 4 C for 1 week. Use a manual defrost freezer and avoid repeated freeze-thaw cycles. |
|
| Shipped at ambient temperature. |
|
| Centrifuge tubes before opening. Reconstituting to a concentration of more than 100 ug/ml is recommended. Dissolve the lyophilized protein in distilled water. |
|
|  |
